GFAP and amyotrophic lateral sclerosis: The apparent independence of sNFL from extra-motor pathology contrasts with the recent report of higher serum GFAP levels in ALS patients with neuropsychological abnormalities (Falzone et al., 2022; Verde et al., 2023).